These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23721110)

  • 21. Private initiatives and policy options: recent health system experience in India.
    Purohit BC
    Health Policy Plan; 2001 Mar; 16(1):87-97. PubMed ID: 11238435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians.
    Billaux M; Borget I; Prognon P; Pineau J; Martelli N
    Aust Health Rev; 2016 Jun; 40(3):257-261. PubMed ID: 26342894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The retail market presents health care organizations with new revenue opportunities.
    Campbell S
    Health Care Strateg Manage; 1998 May; 16(5):19. PubMed ID: 10179046
    [No Abstract]   [Full Text] [Related]  

  • 24. District decision-making for health in low-income settings: a qualitative study in Uttar Pradesh, India, on engaging the private health sector in sharing health-related data.
    Gautham M; Spicer N; Subharwal M; Gupta S; Srivastava A; Bhattacharyya S; Avan BI; Schellenberg J
    Health Policy Plan; 2016 Sep; 31 Suppl 2(Suppl 2):ii35-ii46. PubMed ID: 27591205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant drug development, regulation, and commercialization: an Indian industry perspective.
    Sahoo N; Manchikanti P
    BioDrugs; 2011 Apr; 25(2):105-13. PubMed ID: 21230010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the practice of public or private sector doctors more evidence-based? A qualitative study from Vellore, India.
    Akinyemi OO; Martineau T; Tharyan P
    Int J Evid Based Healthc; 2015 Jun; 13(2):66-76. PubMed ID: 26057650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of enablers of knowledge transfer in the medical industry.
    Tuan HW
    Int J Electron Healthc; 2008; 4(2):132-52. PubMed ID: 18676340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indian vaccine innovation: the case of Shantha Biotechnics.
    Chakma J; Masum H; Perampaladas K; Heys J; Singer PA
    Global Health; 2011 Apr; 7():9. PubMed ID: 21507259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion of diagnostic medical devices and policy implications for India.
    Mahal A; Varshney A; Taman S
    Int J Technol Assess Health Care; 2006; 22(2):184-90. PubMed ID: 16571194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and implementation of a portal for the medical equipment market: MEDICOM.
    Palamas S; Kalivas D; Panou-Diamandi O; Zeelenberg C; van Nimwegen C
    J Med Internet Res; 2001; 3(4):E32. PubMed ID: 11772547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
    Tauqeer F; Myhr K; Gopinathan U
    Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In search of a travel guide-results from a survey of E‑health startup companies].
    Hagen J; Lauer W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Mar; 61(3):291-297. PubMed ID: 29404630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Canadian Natural Health Products (NHP) regulations: industry perceptions and compliance factors.
    Laeeque H; Boon H; Kachan N; Cohen JC; D'Cruz J
    BMC Health Serv Res; 2006 May; 6():63. PubMed ID: 16734916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative study.
    Tsoi B; O'Reilly D; Masucci L; Drummond M; Goeree R
    J Popul Ther Clin Pharmacol; 2015; 22(1):e78-89. PubMed ID: 25715384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hub and spoke model: making rural healthcare in India affordable, available and accessible.
    Devarakonda S
    Rural Remote Health; 2016; 16(1):3476. PubMed ID: 26836754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel approaches to innovation in medical device manufacture.
    McKay I
    Med Device Technol; 2004 Jun; 15(5):24-6. PubMed ID: 15285484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers and enablers to the use of venous leg ulcer clinical practice guidelines in Australian primary care: A qualitative study using the theoretical domains framework.
    Weller CD; Richards C; Turnour L; Patey AM; Russell G; Team V
    Int J Nurs Stud; 2020 Mar; 103():103503. PubMed ID: 31931442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.